Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16

MLA

Nick Andrews, et al. Serogroup C Neisseria Meningitidis Disease Epidemiology, Seroprevalence, Vaccine Effectiveness and Waning Immunity, England, 1998/99 to 2015/16. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdc4f3b456cf70758813248e3f08ffc9&authtype=sso&custid=ns315887.

APA

Nick Andrews, Ray Borrow, Helen Campbell, Shamez N Ladhani, Jay Lucidarme, Helen Findlow, & Ezra Linley. (2019). Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.

Chicago

Nick Andrews, Ray Borrow, Helen Campbell, Shamez N Ladhani, Jay Lucidarme, Helen Findlow, and Ezra Linley. 2019. “Serogroup C Neisseria Meningitidis Disease Epidemiology, Seroprevalence, Vaccine Effectiveness and Waning Immunity, England, 1998/99 to 2015/16,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdc4f3b456cf70758813248e3f08ffc9&authtype=sso&custid=ns315887.